Accessibility Toolbar

Bascom Palmer Eye Institute

Byron L. Lam, M.D.

Bascom Palmer Eye Institute Initiates Pioneering Gene Therapy Targeting Choroideremia

November 17, 2015

A research team at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine has performed gene therapy on a 47-year-old man as part of a Phase 2 clinical trial to treat Choroideremia (CHM), a rare inherited cause of blindness. The Food and Drug Administration approved clinical trial will ultimately treat six patients with CHM to help determine the safety and efficacy of this novel treatment.

Read more about the pioneering gene therapy »